# Treatment Regimens for Patients With Resectable Liver Metastases (PANTER Study)

> **NCT01266187** · NA · TERMINATED · sponsor: **RWTH Aachen University** · enrollment: 16 (actual)

## Conditions studied

- Liver Metastasis

## Interventions

- **PROCEDURE:** adjuvant surgery + FOLFOX + cetuximab
- **PROCEDURE:** perioperative/Folfox + cetuximab

## Key facts

- **NCT ID:** NCT01266187
- **Lead sponsor:** RWTH Aachen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Recruitment difficulities
- **Last updated:** 2015-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01266187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01266187, "Treatment Regimens for Patients With Resectable Liver Metastases (PANTER Study)". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01266187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*